Tokyo-SV MedTech Demo Day
We are opening the door to medical technology the world never sees.
Japan builds extraordinary surgical robotics, imaging AI, neural implants and biosensors. Its hospitals run them every day. Almost none of it ever leaves the country.
On Monday, September 14 at 7:30 PM ET (4:30 PM PT), The Tokyo Silicon Valley MedTech Launchpad (TSVML) is hosting a virtual Demo Day where companies from our current cohort of 20 Japanese MedTech ventures present a US investors, health systems, strategics and distribution partners. For most of them, this is the first time they have told their story to an American audience.
Presenting live from Tokyo, where it is Tuesday morning, September 15.
This is a genuine first look. These are not companies you will find on your deal-flow dashboard. Several are pre-formation spinouts from Japan's leading medical schools. Several have regulatory approval and revenue in Japan and have never opened a US conversation. All of them are building things that change how care gets delivered, not incrementally, but structurally.
What you will see
Companies presenting are drawn from our current cohort, working across:
Surgical robotics and next-generation operating room systems
AI diagnostics and medical imaging, including platforms already cleared and deployed in Japanese hospitals
Implantable neurotechnology, including brain computer interfaces heading into first-in-human trials
Non-invasive biosensing and continuous monitoring
Cardiovascular and structural heart devices
Precision oncology and novel therapeutic platforms
Brain health and early neurological detection
Each company gets a tight 5-minute pitch followed by live Q&A. No panels. No fireside chats. Just the technology, the clinical evidence, and the people who built it.
Who this is for
Investors looking for differentiated deal flow that has not been picked over by every fund on Sand Hill Road.
Health systems and clinicians who want to see what is coming before it arrives, and who can shape how it lands in US practice.
Strategics, distributors and commercial partners looking for technology to bring into the US market, with founders who are actively seeking exactly that.
Format
Two hours, fully virtual on Zoom
Live pitches with real-time Q&A
Follow-up introductions available to registered guests
Sessions in English
About TSVML
TSVML runs an accelerator built for one purpose: taking Japan's best medical technology into the United States. We work hands-on with founders on product market fit, US regulatory strategy, clinical validation and commercial partnerships. Our current cohort is 20 companies deep, spanning pre-formation university spinouts through commercial-stage device makers.
TSVML is supported by the Tokyo Metropolitan Government SUTeam project. More information can be found on the accelerator webpage at: https://tokyomedtech.com
Register now. Seats for live Q&A are limited.